Vusor FC tablets
PDF Leaflet Revision Date: 29 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
To reduce cardiovascular risk and treat hypercholesterolaemia.
Dosage (summary)
5 to 40 mg orally once daily; starting dose usually 5 mg.
Onset of Action / Duration
Onset: 1 week, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Asian ancestry
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Ciclosporin
- Gemfibrozil
- Fibrates
- Protease inhibitors
Contraindications
- Hypersensitivity to rosuvastatin
- Active liver disease
- Severe renal impairment
- Pregnancy and lactation
- Myopathy
Common side effects
- Myalgia
- Constipation
- Nausea
- Headache
- Dizziness
Counselling Points
- Report muscle pain or weakness immediately.
- Avoid alcohol.
- Regular liver function tests recommended.
Serious warnings
- Risk of myopathy and rhabdomyolysis
- Monitor renal function
- Increased liver transaminases
Important Disclaimer
The Vusor FC tablets professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
